Course Name Credits Typesort descending Course Format Release and expiration date
Managing Metastatic NSCLC: Strategies for Treatment Selection
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
Enduring
  • Online CME
07/12/2016 to 03/30/2018
Hemophilia: Triumphs, Challenges, and Shared Decision Making in the Management of Hemophilia B (Community Centers)
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
10/02/2017 to 10/01/2018
Paving the Way to Better Choices for Veterans With Lung Cancer: A Shared Decision-Making Approach to Treatment
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
09/20/2016 to 03/30/2018
CDK 4/6 Inhibitors: New Choices for HR-Positive, HER2-Negative Metastatic Breast Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
09/13/2016 to 05/02/2018
Managing Relapsed/Refractory Myeloma in the Era of New Agents for Treatment
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
12/05/2016 to 04/10/2018
Staying Up to Date on the Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
03/13/2017 to 03/12/2018
Triggering the Immune System: Immune Checkpoint Inhibitors for the Treatment of Non–Small Cell Lung Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
12/21/2016 to 05/09/2018
Current and Future Directions in the Treatment of Colorectal Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
02/21/2017 to 06/20/2018
Current and Future Directions in the Treatment of Pulmonary Neuroendocrine Tumors
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
01/18/2017 to 05/04/2018
Expanded Treatment Options for Metastatic Pancreatic Cancer: Evidence-Based Updates
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
12/21/2016 to 04/03/2018
Incorporating CDK 4/6 Inhibitors in the Treatment of Estrogen Receptor–Positive Breast Cancer: Considerations for Nurses, Patients, and Families
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
02/07/2017 to 04/21/2018
Staying Up to Date on the Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
05/03/2017 to 05/02/2018
Clinical Debates and Consensus Recommendations on the Use of Antiangiogenic Agents in Lung Cancer: A Focus on the Elderly Patient
  • 0.50 AMA PRA Category 1 Credit™ credits
  • 0.50 ANCC credits
  • 0.50 Attendance credits
Enduring
  • Online CME
03/27/2017 to 03/26/2018
The Latest Advances in CAR T-Cell Therapy for Refractory and Relapsed Lymphomas and Leukemias
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
09/12/2017 to 09/11/2018
Autologous Hematopoietic Stem Cell Transplantation and Mobilization in Multiple Myeloma: Current Debate and Developments
  • 1.00 AMA PRA Category 1 Credit™ credit
  • 1.00 ACPE credit
  • 1.00 ANCC credit
  • 1.00 Attendance credit
Enduring
  • Online CME
10/02/2017 to 10/01/2018

Pages